Drug Safety & Pharmacovigilance

End-to-end PV operations, signal management, and aggregate reporting aligned with global regulations.

Reliable PV Systems for Patient Safety and Compliance

Magnus CRO delivers scalable pharmacovigilance services across development and post-marketing. We combine experienced case processors, safety physicians, and quality leads with validated systems and inspection-ready documentation.

ICSR Case Processing

  • Intake & triage (email, portal, call center, literature); duplicates and follow-ups management.
  • Case data entry in Argus/ARISg or sponsor systems; narrative writing and medical assessment.
  • MedDRA coding of AEs and WHO Drug for medications; seriousness, expectedness, and causality assessment.
  • Expedited reporting (SUSARs, 15-day/7-day) to authorities/ethics sites via E2B(R3) gateways.
  • Compliance tracking (due dates, acknowledgments) and reconciliation with clinical databases.

Signal & Risk Management

  • Signal detection using quantitative methods and medical review; signal validation and prioritization.
  • Signal evaluation and recommendations; safety communications and labeling change support.
  • Risk Management Plans (RMPs) and risk minimization measures; effectiveness evaluation.

Aggregate Safety Reporting

  • Development: DSUR authoring, data lock point coordination, listings/TLFs, and medical interpretation.
  • Post-marketing: PSUR/PBRER planning and production; benefit–risk assessment and signal summaries.
  • Periodic safety update schedules, source data reconciliation, and QC/approval workflows.

PV System & Compliance

  • PV System Master File (PSMF) creation/maintenance; QPPV and deputy support where applicable.
  • Safety data exchange agreements (SDEAs), vendor oversight, KPIs, and audit programs.
  • Inspection readiness (EMA, FDA, MHRA): CAPA management, training records, and document control.
  • Literature surveillance: global and local journals; screening, triage, and case creation.

Deliverables

  • Processed ICSRs with medical review, narratives, and compliant submissions (E2B(R3)).
  • Signal detection/evaluation reports and Risk Management Plans (RMPs).
  • DSURs, PSURs/PBRERs, line listings, and cumulative summary outputs.
  • Audit/inspection dossiers, SOPs/WIs, training matrices, and CAPA logs.

Need End-to-End Pharmacovigilance Support?

Speak with our PV leaders about building a compliant safety system, scaling case processing, or preparing aggregate reports.

Contact Us